2040

LAWS OF MARYLAND

Ch. 575

(32) NIMETAZEPAM;

(33)  NITROZEPAM;

(34) NORDIAZEPAM;

[(8A)] (35) Oxazepam;
(36) OXAZOLAM;

[(9)] (37) Paraldehyde;
[(10)] (38) Petrichloral;
[(11)] (39) Phenobarbital;

(40) PINAZEPAM;

(41) PRAZEPAM;

(42) TEMAZEPAM;

(43) TETRAZEPAM;

(44)  TRIAZOLAM;

b.  Any material, compound, mixture, or
preparation which contains any quantity of the following
substances including its salts, isomers (whether optical,
position, or geometric), and salts of such isomers whenever the
existence of such salts, isomers, and salts of isomers is

possible:

(1) Fenfluramine.

c.  Any material, compound, mixture, or
preparation which contains any quantity of the following
substances having a potential for abuse associated with a
stimulant effect on the central nervous system:

(1)  Diethylpropion.

(2)  Pemoline (including organometallic

complexes and chelates thereof).

(3)  Phentermine.

d.  The Department may except by rule any
compound, mixture, or preparation containing any depressant
substance listed in subsection (a) from the application of all or
any part of this act if the compound, mixture, or preparation
contains one or more active medicinal ingredients not having a
depressant effect on the central nervous system, and if the
admixtures are included therein in combinations, quantity,
proportion, or concentration that vitiate the potential for abuse
of the substances which have a depressant effect on the central
nervous system.

(e) Schedule V - In determining that a substance comes
within this schedule, the Department shall find:

1. A low potential for abuse relative to the
substances listed in Schedule IV; and

2. Currently accepted medical use in the United
States; and

3. Limited physical dependence and/or psychological
dependence liability relative to the substances listed in
Schedule IV.